Table 3.
Selected indicators of HSciR performance
| Country | GDP (millions, current US$, 2016)a | Population (thousands, 2016)a | GDP per capita (current US$, 2016)a | No. of publications per 1 million inhabitantsb | No. of first author publications per 1 million inhabitantsb | No. of trials per 1 million inhabitantsc | GERD as a % of GDP d | GERD per capita (in current PPP$)d | Total R&D personnel per million inhabitants (full-time equivalent [FTE])d |
|---|---|---|---|---|---|---|---|---|---|
| Botswana | 15,581 | 2250 | 6924 | 784.80 | 335.96 | 41.33 | 0.53728 | 86.56169 | 570 |
| Kenya | 70,529 | 48,462 | 1455 | 294.79 | 125.27 | 13.19 | 0.78578 | 19.06104 | 1029 |
| Uganda | 24,079 | 41,488 | 580 | 198.85 | 84.27 | 15.69 | 0.17043 | 2.93947 | 42 |
| Zambia | 21,064 | 16,591 | 1270 | 166.23 | 51.89 | 15.79 | 0.27819 | 7.7016 | 163 |
a World Bank. Data from 2016 b Scopus (data publications published between 2008 and 2018) and SciVal (data from 2013 to 2017) c WHO International Clinical Trials Registry Platform and United States National Institutes of Health clinical trials database. Data from 2018 d United Nations Educational, Scientific and Cultural Organization Institute for Statistics (category: science, technology and innovation). Data from most recent available year between 2005 and 2016
GERD gross expenditure on research and development